In this competitive market, companies such as Marijuana Company of America, Inc. (OTC: MCOA) are successfully carving out a niche for themselves due to a unique strategic approach and business model.
Articles
California Wildfires Torch Cannabis Farms at Height of Harvest Season
Just months before California is poised to legalize recreational marijuana, fatal wildfires tearing through three northern counties have scorched an untold number of cannabis farms.
ABcann Global Puts The 'Green' In Green Rush
Seekingalpha.com recently posted an in-depth article looking at ABcann Global (TSX.V: ABCN OTCQB: ABCCF) and how well positioned it is in this emerging market. It's a great read for those interested in this company that we've identified as one of Canada's Strongest Growers.
Standout Players Find Varied, Innovative Means of Serving the Marijuana Industry
Standouts in the diverse cannabis industry include Global Payout, Inc. (GOHE)...
InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) Biosynthesis Technology Demonstrates Robust Diversity
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids
ChineseInvestors.com, Inc. (CIIX) Poised to be First to Market in China’s Multibillion-Dollar Skin Care Industry with Line of Cannabidiol-Based Products
ChineseInvestors.com (OTCQB: CIIX) is quickly moving into the multibillion-dollar Chinese skin care industry and is introducing its first line of cannabidiol (CBD) based skin care products.
Cannabis gets in on Pumpkin Spice Season
GOOD CO-OP releases Pumpkin Spice Blondie exclusively on Eaze.
5 CANNABIS BIOTECH STOCKS TO WATCH
These 5 Biotechs including InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) have a combined market cap of over $4 Billion. What should investors know about future growth for these companies?
India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
MCIG Enters into the Cryptocurrency Market, Partnering with Render Payment
mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, enters into the cryptocurrency market, partnering with Render Payment during its Pre-ICO (Initial Coin Offering).
Corporate Canada warms to marijuana industry
With expectations of the Canadian Marijuana Industry exploding, well-known figures from corporate Canada are moving into prominent positions within the industry.
PotNetwork Holding, Inc. (POTN) Subsidiary Records 20.9% Monthly Revenue Growth in August, Strengthens Advisory Board
PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved record-breaking revenues for the month of August.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Frontrunner in the Delivery of Non-Psychoactive Cannabinoids
Lexaria Biosciences Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has enhanced the ability of cannabinoid-products companies to deliver active ingredients to the body with its patent-protected technology.
InMed Pharmaceuticals pursues medical qualities of cannabis — no smoke
People with such serious medical conditions as glaucoma and multiple sclerosis may smoke marijuana to deliver a range of chemicals that they believe helps improve their conditions. The problem is that a joint might just be one of the least effective methods to deliver some of the 90+ cannabinoids found in cannabis.
Organigram Expanding Operations, Hiring Up To 140 New Employees, Will Raise Annual Output to 25,000 kg
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) is undergoing a production-facility expansion that will more than triple the size of its operations. The multi-million-dollar project will meet the growing needs of the Company’s medical patient base, as well as prepare Organigram for the legal, adult-recreational marijuana market.